282 related articles for article (PubMed ID: 17239313)
21. [Renal cell carcinoma].
Fornara P; Hoda MR
Urologe A; 2011 Sep; 50 Suppl 1():219-22. PubMed ID: 21837488
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant therapy in renal cell carcinoma.
Gul A; Rini BI
Cancer; 2019 Sep; 125(17):2935-2944. PubMed ID: 31225907
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
[TBL] [Abstract][Full Text] [Related]
24. Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence.
de Riese W; Goldenberg K; Allhoff E; Stief C; Schlick R; Liedke S; Jonas U
Int Urol Nephrol; 1991; 23(1):13-25. PubMed ID: 1938215
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Marshall FF
J Urol; 2005 Nov; 174(5):1782-3. PubMed ID: 16217283
[No Abstract] [Full Text] [Related]
26. Updates to the Management of Kidney Cancer.
Jonasch E
J Natl Compr Canc Netw; 2018 May; 16(5S):639-641. PubMed ID: 29784745
[TBL] [Abstract][Full Text] [Related]
27. Therapy of local recurrence of renal cell carcinoma.
Wiesner C; Jakse G; Rohde D
Oncol Rep; 2002; 9(1):189-92. PubMed ID: 11748481
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in renal cell carcinoma.
Volpe A; Patard JJ
World J Urol; 2010 Jun; 28(3):319-27. PubMed ID: 20364259
[TBL] [Abstract][Full Text] [Related]
29. The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma.
Jeon SH; Chang SG; Kim JI
Anticancer Res; 1999; 19(6C):5593-7. PubMed ID: 10697624
[TBL] [Abstract][Full Text] [Related]
30. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma.
Pound CR; Partin AW; Epstein JI; Simons JW; Marshall FF
Urology; 1993 Sep; 42(3):243-8. PubMed ID: 8379023
[TBL] [Abstract][Full Text] [Related]
31. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma.
Lin PH; Terramani TT; Bush RL; Keane TE; Moore RG; Lumsden AB
J Vasc Surg; 2003 Sep; 38(3):446-50. PubMed ID: 12947251
[TBL] [Abstract][Full Text] [Related]
32. Systematic Review of the Management of Local Kidney Cancer Relapse.
Kriegmair MC; Bertolo R; Karakiewicz PI; Leibovich BC; Ljungberg B; Mir MC; Ouzaid I; Salagierski M; Staehler M; van Poppel H; Wood CC; Capitanio U;
Eur Urol Oncol; 2018 Dec; 1(6):512-523. PubMed ID: 31158097
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
[TBL] [Abstract][Full Text] [Related]
34. [Long-term results in the treatment of 100 metastatic hypernephroid carcinomas].
Falk W; Halama JM; Halama J
Strahlenther Onkol; 1990 Apr; 166(4):256-64. PubMed ID: 2139518
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.
Basting R; Corvin S; Händel D; Hinke A; Schmidt D
Anticancer Res; 1999; 19(2C):1493-5. PubMed ID: 10365130
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
Belldegrun A; Tsui KH; deKernion JB; Smith RB
J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
[TBL] [Abstract][Full Text] [Related]
37. Surgical enucleation for renal cell carcinoma (RCC). Prognostic significance of tumour stage, grade and DNA ploidy.
Di Silverio F; Sciarra A; Flammia GP; Mariani M; De Vico A; Buscarini M
Scand J Urol Nephrol; 1997 Apr; 31(2):123-8. PubMed ID: 9165573
[TBL] [Abstract][Full Text] [Related]
38. Clinical study of brain metastasis of renal cell carcinoma.
Harada Y; Nonomura N; Kondo M; Nishimura K; Takahara S; Miki T; Okuyama A
Eur Urol; 1999 Sep; 36(3):230-5. PubMed ID: 10450008
[TBL] [Abstract][Full Text] [Related]
39. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
40. Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.
Blick C; Ritchie AWS; Eisen T; Stewart GD
Nat Rev Urol; 2017 Dec; 14(12):753-759. PubMed ID: 28762388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
